Cerus Corporation

CERS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.

2.20 0.06 −2.65%
Market cap
$455.5M
P/E
0.0×
Fwd P/E
−81.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.36 1.44 1.68 1.35
P/FCF ratio
0.00 0.00 354.35 1,815.53
P/Operating CF
(220.09) (115.89) 63.33 158.28
P/B ratio
8.28 5.17 6.04 4.90
Price to Tangible BV
8.44 5.28 6.17 5.01
EV/Sales
2.40 1.46 1.68 1.38
EV/EBITDA
9,004.57 0.00 0.00 0.00
EV/Operating CF
245.88 135.92 81.38 87.33
EV/FCF
(324.93) (293.71) 355.26 1,853.58
Quick Ratio
1.02 1.02 1.12 1.22
Current Ratio
1.83 1.63 1.73 1.89
Net Debt/EBITDA
(6.19) 47.38 (4.07) 3.95
Debt/Assets
31.64% 38.06% 37.81% 39.46%
Debt/Equity
0.92 1.24 1.29 1.36
Asset Turnover
1.19 1.14 1.11 1.12
Operating CF/Net income
0.91 1.86 (2.84) (101.42)
Capex/Depreciation
(1.89) (0.52) (3.33) (4.80)
Interest Coverage
(1.08) (0.19) (0.33) 0.58
Research and Development Expense of Revenue
22.73% 24.26% 25.38% 26.27%
Selling, General and Administrative Expense of Revenue
36.12% 33.31% 32.25% 30.91%
Intangible Assets out of Total Assets
0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
8.68% 8.19% 7.63% 9.34%
Graham Net Nets
0.04 0.06 0.04 0.05
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(1.20%) (2.75%) (3.89%) (5.25%)
Free Cash Flow Yield
(0.31%) (0.34%) 0.28% 0.06%
Revenue per Share
0.32 0.31 0.34 0.31
Operating CF per Share
(0.01) (0.02) 0.03 0.01
Capex per Share
0.00 0.00 (0.01) (0.01)
Free Cash Flow per Share
(0.02) (0.02) 0.03 0.00
Cash per Share
0.28 0.41 0.43 0.41
Shareholders Equity per Share
0.35 0.35 0.34 0.32
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.35 0.35 0.34 0.32
Free Cash Flow
(3.53) (3.28) 4.89 0.09
Working Capital
71.52 67.96 73.58 78.69
Capital Expenditures
(0.87) (0.23) (1.31) (1.83)
Net Current Asset Value
22.84 20.72 17.49 14.15
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.00 0.02 0.03
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
31.18 27.83 30.08 27.07
Average Payables
32.02 29.73 24.85 20.67
Average Inventory
60.17 54.64 47.13 44.84
Average Assets
209.13 214.84 211.39 202.36
Average Common Equity
63.44 62.26 60.93 58.24

Fold the line items

Columns are period end dates